Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Gabay

Showing results (31-40 of 259) with videos related to

Pageof 26
Sort By:
Lancet (London, England)|August 6, 2013
Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' replyCem Gabay, Arthur Kavanaugh,
Joint Bone Spine|August 9, 2012
Hand osteoarthritis: new insightsOdile Gabay, Cem Gabay
The New England Journal of Medicine|January 13, 2006
Images in clinical medicine. Milwaukee shoulderMarcia S Genta, Cem Gabay
Arthritis Research & Therapy|June 13, 2009
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseasesCem Gabay, Iain B McInnes
Journal of Leukocyte Biology|February 13, 2015
Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditionsCem Gabay, Jennifer E Towne
Rheumatic Diseases Clinics of North America|April 6, 2004
Cytokines in the rheumatic diseasesWilliam P Arend, Cem Gabay
Joint Bone Spine|April 10, 2018
Biological agents in the management of adult-onset Still's diseaseCharlotte Girard-Guyonvarc'h, Cem Gabay
Revue Medicale Suisse|April 12, 2006
[Septic arthritis]C Medinger Sadowski, Cem Gabay
Arthritis Research & Therapy|August 2, 2006
The role of leptin in innate and adaptive immune responsesEiva Bernotiene, Gaby Palmer, Cem Gabay
The Journal of Rheumatology|July 17, 2014
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?Elena Ciubotariu, Cem Gabay, Axel Finckh, et al.
Pageof 26

Showing results (31-40 of 259) with videos related to

Sort By:
Pageof 26
Lancet (London, England)|August 6, 2013
Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' replyCem Gabay, Arthur Kavanaugh,
Joint Bone Spine|August 9, 2012
Hand osteoarthritis: new insightsOdile Gabay, Cem Gabay
The New England Journal of Medicine|January 13, 2006
Images in clinical medicine. Milwaukee shoulderMarcia S Genta, Cem Gabay
Arthritis Research & Therapy|June 13, 2009
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseasesCem Gabay, Iain B McInnes
Journal of Leukocyte Biology|February 13, 2015
Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditionsCem Gabay, Jennifer E Towne
Rheumatic Diseases Clinics of North America|April 6, 2004
Cytokines in the rheumatic diseasesWilliam P Arend, Cem Gabay
Joint Bone Spine|April 10, 2018
Biological agents in the management of adult-onset Still's diseaseCharlotte Girard-Guyonvarc'h, Cem Gabay
Revue Medicale Suisse|April 12, 2006
[Septic arthritis]C Medinger Sadowski, Cem Gabay
Arthritis Research & Therapy|August 2, 2006
The role of leptin in innate and adaptive immune responsesEiva Bernotiene, Gaby Palmer, Cem Gabay
The Journal of Rheumatology|July 17, 2014
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?Elena Ciubotariu, Cem Gabay, Axel Finckh, et al.
Pageof 26